JP2023158690A - Vitamin b2-containing beverage - Google Patents
Vitamin b2-containing beverage Download PDFInfo
- Publication number
- JP2023158690A JP2023158690A JP2022068610A JP2022068610A JP2023158690A JP 2023158690 A JP2023158690 A JP 2023158690A JP 2022068610 A JP2022068610 A JP 2022068610A JP 2022068610 A JP2022068610 A JP 2022068610A JP 2023158690 A JP2023158690 A JP 2023158690A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- riboflavin
- beverage
- isomaltulose
- maltodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 title claims abstract description 140
- 235000013361 beverage Nutrition 0.000 title claims abstract description 61
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 90
- 229960002477 riboflavin Drugs 0.000 claims abstract description 90
- 235000019192 riboflavin Nutrition 0.000 claims abstract description 49
- 239000002151 riboflavin Substances 0.000 claims abstract description 49
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 41
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 41
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 41
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims abstract description 40
- 229960003495 thiamine Drugs 0.000 claims abstract description 23
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 17
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 16
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 16
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 13
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 9
- -1 fursulthiamine Chemical compound 0.000 claims description 8
- 235000019157 thiamine Nutrition 0.000 claims description 8
- 239000011721 thiamine Substances 0.000 claims description 8
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 7
- FHSWKZUNNVWBSG-UHFFFAOYSA-M 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol;dodecyl hydrogen sulfate;dodecyl sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N FHSWKZUNNVWBSG-UHFFFAOYSA-M 0.000 claims description 5
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 claims description 4
- OHSHFZJLPYLRIP-BMZHGHOISA-M Riboflavin sodium phosphate Chemical compound [Na+].OP(=O)([O-])OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O OHSHFZJLPYLRIP-BMZHGHOISA-M 0.000 claims description 4
- 229960002873 benfotiamine Drugs 0.000 claims description 4
- BTNNPSLJPBRMLZ-LGMDPLHJSA-N benfotiamine Chemical compound C=1C=CC=CC=1C(=O)SC(/CCOP(O)(O)=O)=C(/C)N(C=O)CC1=CN=C(C)N=C1N BTNNPSLJPBRMLZ-LGMDPLHJSA-N 0.000 claims description 4
- GFEGEDUIIYDMOX-BMJUYKDLSA-N n-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[(z)-3-[[(z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-hydroxypent-2-en-3-yl]disulfanyl]-5-hydroxypent-2-en-2-yl]formamide Chemical compound C=1N=C(C)N=C(N)C=1CN(C=O)C(\C)=C(CCO)/SSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N GFEGEDUIIYDMOX-BMJUYKDLSA-N 0.000 claims description 4
- 229960001385 thiamine disulfide Drugs 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 abstract description 34
- 229920002774 Maltodextrin Polymers 0.000 abstract description 34
- 229940035034 maltodextrin Drugs 0.000 abstract description 34
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 239000008213 purified water Substances 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 16
- 229960004106 citric acid Drugs 0.000 description 14
- 235000015165 citric acid Nutrition 0.000 description 14
- 235000015110 jellies Nutrition 0.000 description 13
- 239000008274 jelly Substances 0.000 description 13
- 239000012488 sample solution Substances 0.000 description 13
- 235000019645 odor Nutrition 0.000 description 12
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 8
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 7
- 229920002148 Gellan gum Polymers 0.000 description 7
- 229960002303 citric acid monohydrate Drugs 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 235000010492 gellan gum Nutrition 0.000 description 7
- 239000000216 gellan gum Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 229920002245 Dextrose equivalent Polymers 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920006310 Asahi-Kasei Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- JTLXCMOFVBXEKD-FOWTUZBSSA-N fursultiamine Chemical compound C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N JTLXCMOFVBXEKD-FOWTUZBSSA-N 0.000 description 1
- 229950006836 fursultiamine Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- UDCIYVVYDCXLSX-SDNWHVSQSA-N n-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[(e)-5-hydroxy-3-(propyldisulfanyl)pent-2-en-2-yl]formamide Chemical compound CCCSS\C(CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N UDCIYVVYDCXLSX-SDNWHVSQSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229950001574 riboflavin phosphate Drugs 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
Abstract
Description
本発明は、ビタミンB2類を含有する飲料に関する。 The present invention relates to a beverage containing vitamin B2.
マルトデキストリンは一般的に、澱粉分解物の加水分解の程度を示すデキストロース当量(DE)が10~20の糖質であり、小腸での吸収が比較的速く、摂取後に速やかにエネルギー源となりうることが知られており、イソマルツロースは、別名パラチノース(登録商標)ともいい、グルコ-スがフルクト-スにα- 1,6グルコシル結合することによって構成された二糖であり、消化吸収が穏やかであることから、持続性のエネルギー源となりうることが知られている。 Maltodextrin is generally a carbohydrate with a dextrose equivalent (DE) of 10 to 20, which indicates the degree of hydrolysis of starch decomposition products, and is absorbed relatively quickly in the small intestine, so it can quickly become an energy source after ingestion. Isomaltulose, also known as Palatinose (registered trademark), is a disaccharide composed of glucose linked with α-1,6 glucosyl to fructose, and is easily digested and absorbed. Therefore, it is known that it can be used as a sustainable energy source.
また、ビタミンのうち、ビタミンB1およびその誘導体又はそれらの塩(以下、「ビタミンB1類」という)は、グルコース代謝と分岐アミノ酸代謝などに関与し、疲労回復などの様々な薬効が知られている水溶性ビタミンであり、ビタミンB2およびその誘導体又はそれらの塩(以下、「ビタミンB2類」という)は、TCA回路、電子伝達系、脂肪酸のβ酸化等のエネルギー代謝に関与し、エネルギー産生に関与する水溶性ビタミンである。
近年、運動時などのエネルギー補給を目的とした清涼飲料水(ゼリー飲料を含む)として、エネルギー源となる糖質であるマルトデキストリンやイソマルツロース、エネルギー産生に寄与するビタミンBを含む製品が流通・販売されている。
Furthermore, among vitamins, vitamin B1 and its derivatives or their salts (hereinafter referred to as "vitamin B1") are involved in glucose metabolism and branched amino acid metabolism, and are known to have various medicinal effects such as relieving fatigue. Vitamin B2 and its derivatives or their salts (hereinafter referred to as "vitamin B2") are water-soluble vitamins that are involved in energy metabolism such as the TCA cycle, electron transport system, and β-oxidation of fatty acids, and are involved in energy production. It is a water-soluble vitamin.
In recent years, products containing maltodextrin and isomaltulose, which are carbohydrates that serve as energy sources, and vitamin B, which contributes to energy production, have been distributed as soft drinks (including jelly drinks) for the purpose of replenishing energy during exercise.・It is on sale.
今までにビタミンB2類、及び生薬由来成分、及びポリビニルピロリドンを配合する内服液剤のビタミンB2類の含量低下を、没食子酸プロピルを配合することにより、改善できる技術が知られている(特許文献1)。 Until now, a technique has been known that can improve the decrease in the content of vitamin B2 in an oral solution containing vitamin B2, herbal medicine-derived ingredients, and polyvinylpyrrolidone by incorporating propyl gallate (Patent Document 1) ).
本発明者らは、ビタミンB2類とマルトデキストリンとイソマルツロースを含む飲料の開発を行う過程で、ビタミンB2類の安定性が課題となった。さらに、ビタミンB2類由来の不快臭の発生が問題となった。 In the process of developing a beverage containing vitamin B2, maltodextrin, and isomaltulose, the present inventors encountered the problem of stability of vitamin B2. Furthermore, the generation of unpleasant odors derived from vitamin B2s became a problem.
すなわち、本発明は、ビタミンB2類、マルトデキストリン、及びイソマルツロースを含有した飲料において、ビタミンB2類の含量低下を抑制した飲料を提供することを目的とする。さらに、ビタミンB2類、マルトデキストリン、及びイソマルツロース飲料において、ビタミンB2類由来の不快臭を緩和した、飲料を提供することを目的とする。 That is, an object of the present invention is to provide a beverage containing vitamin B2, maltodextrin, and isomaltulose in which a decrease in the content of vitamin B2 is suppressed. Furthermore, it is an object of the present invention to provide a vitamin B2, maltodextrin, and isomaltulose beverage in which the unpleasant odor derived from vitamin B2 is alleviated.
そこで本発明者は、上記課題を解決すべく鋭意検討を重ねた結果、意外なことにビタミンB2類、マルトデキストリン、及びイソマルツロースを含有した飲料において、ビタミンB2類とマルトデキストリンを特定の濃度以上配合すると、ビタミンB2類の含量低下を抑制した飲料を提供できることを見出し、本発明を完成した。
さらに、ビタミンB2類とマルトデキストリンを特定濃度以上含有し、かつイソマルツロースを含有する飲料に、ビタミンB1類を特定濃度配合すると、ビタミンB2類由来の不快臭を緩和した飲料を提供できることを見出し、本発明を完成した。
かかる知見により得られた本発明の態様は次のとおりである。
(1)a)リボフラビン換算で0.0011~0.01w/w%のビタミンB2、その誘導体、及びそれらの塩からなる群から選択される少なくとも1種のビタミンB2類、及び、b)15w/w%以上のマルトデキストリン、及び、c)イソマルツロースを含有することを特徴とする飲料、
(2)c)イソマルツロースの濃度が0.1~10w/w%である、(1)に記載の飲料、
(3)a)ビタミンB2類がリボフラビン、リボフラビン酪酸エステル、及びリボフラビンリン酸エステルナトリウムからなる群から選択される少なくとも1種である、(1)~(2)に記載の飲料、
(4)液状、又はゲル状である、(1)~(3)のいずれかに記載の飲料
(5)pHが2.0~5.0である(1)~(4)のいずれかに記載の飲料、
(6)d)0.00025~0.0025w/w%のビタミンB1、その誘導体、及びそれらの塩からなる群から選択される少なくとも1種のビタミンB1類を含有することを特徴とする、(1)~(5)のいずれかに記載の飲料、
(7)d)ビタミンB1類がチアミン、フルスルチアミン、チアミンジスルフィド、ベンフォチアミン、ラウリル硫酸チアミン、及びそれらの塩からなる群から選択される少なくとも1種である、(6)に記載の飲料、
である。
Therefore, as a result of extensive studies to solve the above problems, the present inventor unexpectedly found that vitamin B2 and maltodextrin were added to a specific concentration in a beverage containing vitamin B2, maltodextrin, and isomaltulose. The present invention was completed based on the discovery that the above blending can provide a beverage in which the content of vitamin B2 is suppressed from decreasing.
Furthermore, we have discovered that if a specific concentration of vitamin B1 is added to a beverage containing vitamin B2 and maltodextrin at a specific concentration or higher, and isomaltulose, it is possible to provide a beverage that alleviates the unpleasant odor derived from vitamin B2. , completed the invention.
Aspects of the present invention obtained from this knowledge are as follows.
(1) a) at least one type of vitamin B2 selected from the group consisting of vitamin B2, derivatives thereof, and salts thereof in an amount of 0.0011 to 0.01 w/w% calculated as riboflavin, and b) 15 w/w% A beverage characterized by containing w% or more of maltodextrin, and c) isomaltulose,
(2) c) The beverage according to (1), wherein the concentration of isomaltulose is 0.1 to 10 w/w%,
(3) a) The beverage according to (1) to (2), wherein the vitamin B2 is at least one selected from the group consisting of riboflavin, riboflavin butyrate, and sodium riboflavin phosphate;
(4) The beverage according to any one of (1) to (3), which is in liquid or gel form. (5) The beverage according to any one of (1) to (4), which has a pH of 2.0 to 5.0. Beverages mentioned;
(6) d) containing 0.00025 to 0.0025 w/w% of at least one type of vitamin B1 selected from the group consisting of vitamin B1, derivatives thereof, and salts thereof; The beverage according to any one of 1) to (5),
(7) d) The beverage according to (6), wherein the vitamin B1 is at least one selected from the group consisting of thiamine, fursulthiamine, thiamine disulfide, benfotiamine, thiamine lauryl sulfate, and salts thereof. ,
It is.
本発明により、ビタミンB2類、マルトデキストリン、及びイソマルツロースを含有した飲料において、ビタミンB2類の含量低下を抑制した飲料を提供することが可能となった。
さらに、ビタミンB2類由来の不快臭を緩和した飲料を提供することが可能となった。
According to the present invention, it has become possible to provide a beverage containing vitamin B2, maltodextrin, and isomaltulose in which a decrease in the content of vitamin B2 is suppressed.
Furthermore, it has become possible to provide a beverage in which the unpleasant odor derived from vitamin B2 is alleviated.
本発明におけるビタミンB2類とは、ビタミンB2若しくはその誘導体又はそれらの塩であり、食品、医薬部外品、医薬品などに通常使用されるものであれば、特に限定されない。本発明におけるビタミンB2類とは、例えば、リボフラビン、リン酸リボフラビン、酪酸リボフラビン、フラビンアデニンジヌクレオチド及びそれらの塩などを挙げることができる。本発明におけるビタミンB2類は、公知の方法により製造できるものであり、市販品であるDSM(株)製のリボフラビンやリボフラビン5’-リン酸エステルナトリウム、岩城製薬(株)製のリボフラビン5’-リン酸エステルナトリウム等を用いることができる。ビタミンB2類のうち、好ましいものとしては、リボフラビン、リボフラビン酪酸エステル、リボフラビン5’-リン酸エステルナトリウムである。本発明におけるビタミンB2類の含有量は、飲料中にリボフラビンとして0.0011w/w%以上であり、好ましくは0.0011w/w%~0.01w/w%、より好ましくは0.0011w/w%~0.005w/w%である。 The vitamin B2s in the present invention are vitamin B2, derivatives thereof, or salts thereof, and are not particularly limited as long as they are commonly used in foods, quasi-drugs, pharmaceuticals, and the like. Examples of vitamin B2 in the present invention include riboflavin, riboflavin phosphate, riboflavin butyrate, flavin adenine dinucleotide, and salts thereof. Vitamin B2 in the present invention can be produced by a known method, and commercially available products such as riboflavin and sodium riboflavin 5'-phosphate produced by DSM Co., Ltd., and riboflavin 5'- produced by Iwaki Pharmaceutical Co., Ltd. Sodium phosphate ester and the like can be used. Preferred among vitamin B2 are riboflavin, riboflavin butyrate, and sodium riboflavin 5'-phosphate. The content of vitamin B2 in the present invention is 0.0011 w/w% or more as riboflavin in the beverage, preferably 0.0011 w/w% to 0.01 w/w%, more preferably 0.0011 w/w % to 0.005 w/w%.
本発明におけるマルトデキストリンとは、デキストロース当量(DE)が10~20程度であり、食品、医薬部外品、医薬品などに通常使用されるものであれば、特に限定されない。本発明におけるマルトデキストリンは、公知の方法により製造できるものであり、市販品である松谷化学工業(株)製のTK-16(DE16~19)やパインデックス#2(DE10~12)等を用いることができる。本発明におけるマルトデキストリンの含有量は、飲料中に15w/w%以上であり、好ましくは15w/w%~30w/w%で、より好ましくは15w/w%~25w/w%である。 Maltodextrin in the present invention is not particularly limited as long as it has a dextrose equivalent (DE) of about 10 to 20 and is commonly used in foods, quasi-drugs, pharmaceuticals, etc. Maltodextrin in the present invention can be produced by a known method, and commercially available products such as TK-16 (DE16-19) and Paindex #2 (DE10-12) manufactured by Matsutani Chemical Industry Co., Ltd. are used. be able to. The content of maltodextrin in the present invention is 15 w/w% or more in the beverage, preferably 15 w/w% to 30 w/w%, more preferably 15 w/w% to 25 w/w%.
本発明におけるイソマルツロースとは、別名パラチノース(登録商標)ともいい、グルコ-スがフルクト-スにα- 1,6グルコシル結合することによって構成された二糖で、甘味料として用いられるものであれば、特に制限されない。本発明におけるイソマルツロースは、公知の方法により製造できるものであり、市販品である三井製糖(株)製の結晶パラチノースPST-Nや粉末パラチノースPST-NP等を用いることができる。本発明におけるイソマルツロースの含有量は、特に制限されるものではないが、本発明の効果の点から、飲料中に0.01w/w%以上配合するのが好ましく、好ましくは0.01w/w%~10w/w%で、より好ましくは0.5w/w%~10w/w%で、さらに好ましくは0.5w/w%~5w/w%ある。 Isomaltulose in the present invention is also referred to as Palatinose (registered trademark), and is a disaccharide composed of glucose linked to fructose with an α-1,6 glucosyl bond, and is used as a sweetener. If so, there are no particular restrictions. Isomaltulose in the present invention can be produced by a known method, and commercial products such as crystalline Palatinose PST-N and powdered Palatinose PST-NP manufactured by Mitsui Sugar Co., Ltd. can be used. The content of isomaltulose in the present invention is not particularly limited, but from the viewpoint of the effects of the present invention, it is preferably blended in the beverage at 0.01 w/w% or more, preferably 0.01 w/w% or more. The content is from w/w% to 10w/w%, more preferably from 0.5w/w% to 10w/w%, even more preferably from 0.5w/w% to 5w/w%.
本発明におけるビタミンB1類とは、ビタミンB1若しくはその誘導体又はそれら塩であり、食品、医薬部外品、医薬品などに通常使用されるものであれば、特に限定されない。本発明におけるビタミンB1類とは、例えば、チアミン及びその塩、ジセチアミン、フルスルチアミン、チアミンジスルフィド、ビスベンチアミン、ビスイブチアミン、ベンフォチアミン、シコチアミン、オクトチアミン、プロスルチアミン等のチアミン誘導体及びそれらの塩等が挙げられる。前記それらの塩としては硝酸塩、塩酸塩、ラウリル硫酸塩等が挙げられる。また、本発明におけるビタミンB1類は、公知の方法により製造できるものであり、市販品であるDSM(株)製のチアミン硝酸塩や、(株)タイショーテクノス製のラウリル硫酸チアミン、渡辺ケミカル(株)製のフルスルチアミン等を用いることをできる。ビタミンB1類のうち、好ましいものとしては、チアミン、フルスルチアミン、チアミンジスルフィド、ベンフォチアミン、ラウリル硫酸チアミンおよびそれらの塩であり、さらに好ましくは、チアミン、フルスルチアミン、ラウリル硫酸チアミンおよびそれらの塩である。本発明におけるビタミンB1類の含有量は、本発明の効果の点から飲料中に0.00025~0.0025w/w%が好ましく、より好ましくは0.00028w/w%~0.002w/w%である。 The vitamin B1 class in the present invention is vitamin B1, a derivative thereof, or a salt thereof, and is not particularly limited as long as it is commonly used in foods, quasi-drugs, pharmaceuticals, and the like. In the present invention, vitamin B1 includes, for example, thiamine and its salts, thiamine derivatives such as dicethiamine, fursulthiamine, thiamine disulfide, bisbenthiamine, bisbuthiamine, benfotiamine, cicothiamine, octothiamine, and prosulthiamine; Examples include salts thereof. Examples of the salts thereof include nitrates, hydrochlorides, lauryl sulfates, and the like. Further, the vitamin B1 type in the present invention can be produced by a known method, and commercially available thiamine nitrate manufactured by DSM Co., Ltd., thiamine lauryl sulfate manufactured by Taisho Technos Co., Ltd., and Watanabe Chemical Co., Ltd. Fursultiamine, etc., manufactured by Co., Ltd., can be used. Among vitamin B1, preferred are thiamine, fursulthiamine, thiamine disulfide, benfotiamine, thiamine lauryl sulfate, and salts thereof, and more preferred are thiamine, fursulthiamine, thiamine lauryl sulfate, and their salts. It's salt. The content of vitamin B1 in the present invention is preferably 0.00025 to 0.0025 w/w%, more preferably 0.00028 w/w% to 0.002 w/w% in the beverage from the viewpoint of the effects of the present invention. It is.
本発明の飲料のpHは、常温で好ましくはpH2~7であり、風味及び微生物の繁殖を抑える観点から、さらに好ましくは、pH3~4である。上記のpHにするためのpH調整剤としては、食品、医薬部外品、医薬品などに通常使用されるpH調整剤を使用することができる。例えば、クエン酸、リンゴ酸、酒石酸、酢酸等の有機酸及びそれらの塩、リン酸、塩酸等の無機酸およびそれらの塩、水酸化ナトリウム等の無機塩基等が挙げられる。風味の観点から、好ましくは、クエン酸、リンゴ酸、リン酸、グルコン酸およびそれらの塩である。 The pH of the beverage of the present invention is preferably 2 to 7 at room temperature, and more preferably 3 to 4 from the viewpoint of flavor and suppressing the growth of microorganisms. As a pH adjuster for adjusting the above pH, a pH adjuster commonly used for foods, quasi-drugs, pharmaceuticals, etc. can be used. Examples include organic acids and salts thereof such as citric acid, malic acid, tartaric acid, and acetic acid, inorganic acids and salts thereof such as phosphoric acid and hydrochloric acid, and inorganic bases such as sodium hydroxide. From the viewpoint of flavor, citric acid, malic acid, phosphoric acid, gluconic acid and salts thereof are preferred.
本発明の飲料には、本発明の効果を損なわない範囲で、その他の成分として、ビタミン(ビタミンB1類、ビタミンB2類を除く)、ミネラル、アミノ酸又はその塩、植物抽出物、乳酸菌、果汁等の成分を適宜に含有させることができる。さらに、本発明の飲料には、本発明の効果を損なわない範囲で、抗酸化剤、着色料、香料、矯味剤、界面活性剤、増粘剤、安定剤、保存料、甘味料、酸味料等の添加剤を適宜配合することもできる。 The beverage of the present invention may contain other ingredients such as vitamins (excluding vitamin B1 and vitamin B2), minerals, amino acids or their salts, plant extracts, lactic acid bacteria, fruit juice, etc., to the extent that they do not impair the effects of the present invention. Components may be included as appropriate. Furthermore, the beverage of the present invention may contain antioxidants, colorants, flavors, corrigents, surfactants, thickeners, stabilizers, preservatives, sweeteners, and acidulants to the extent that the effects of the present invention are not impaired. It is also possible to appropriately mix additives such as the following.
本発明の飲料は、特に限定されるものではなく、例えば、液体飲料、ゼリー飲料、スムージー飲料、果汁や果肉を含む飲料やアイススラリーのような凍結飲料であっても良く、一般食品だけでなく、機能性表示食品や栄養機能食品、特定保健用食品もあり得る。また、液体飲料としては、健康飲料、清涼飲料、炭酸飲料、スポーツ・機能性飲料、アルコール飲料、ノンアルコール飲料、乳飲料、茶飲料、コーヒー飲料、果実・野菜系飲料等があげられ、特に液体飲料、ゼリー飲料に有用である。また、そのまま飲用可能である点で、容器詰め飲料であることが好ましい。 The beverage of the present invention is not particularly limited, and may be, for example, a liquid beverage, a jelly beverage, a smoothie beverage, a beverage containing fruit juice or pulp, or a frozen beverage such as an ice slurry, and is not limited to general foods. There may also be foods with functional claims, foods with nutritional function claims, and foods for specified health uses. Liquid drinks include health drinks, soft drinks, carbonated drinks, sports/functional drinks, alcoholic drinks, non-alcoholic drinks, milk drinks, tea drinks, coffee drinks, fruit and vegetable drinks, etc. Useful in beverages and jelly drinks. Moreover, it is preferable that the beverage be packaged in a container because it can be drunk as is.
本発明の飲料を容器詰めとする場合、その容器は、特に限定されず、具体的には、ビン、缶、PETボトル、パウチ容器、紙パックなどが挙げられ、好ましくはビン、缶、PETボトル、パウチ容器である。容量についても特に限定されるものではないが、液体飲料の場合、具体的には、好ましくは30ml~500mlであり、より好ましくは50ml~300mlであり、さらに好ましくは100ml~200mlである。ゼリー飲料の場合、具体的には、10g~300gが好ましく、15g~200gがより好ましく、30g~200gがさらに好ましい。 When the beverage of the present invention is packaged in a container, the container is not particularly limited, and specific examples include bottles, cans, PET bottles, pouch containers, paper packs, etc., and preferably bottles, cans, and PET bottles. , a pouch container. The capacity is also not particularly limited, but in the case of liquid beverages, specifically, it is preferably 30 ml to 500 ml, more preferably 50 ml to 300 ml, and still more preferably 100 ml to 200 ml. In the case of a jelly drink, specifically, the amount is preferably 10 g to 300 g, more preferably 15 g to 200 g, even more preferably 30 g to 200 g.
ゼリー飲料に配合する増粘剤またはゲル化剤としては、ジェランガム、キサンタンガム、グァーガム、ローカストビーンガム、カラギーナン、寒天、グルコマンナン、ペクチン、ゼラチン、メチルセルロース、アルギン酸又はその塩などが挙げられる。 Thickeners or gelling agents to be added to jelly drinks include gellan gum, xanthan gum, guar gum, locust bean gum, carrageenan, agar, glucomannan, pectin, gelatin, methylcellulose, alginic acid or its salts, and the like.
本発明の飲料は、常法により製造することができ、その方法は特に限定されるものではない。本発明の飲料を液体飲料とする場合、例えば、各成分をはかりとり、適量の精製水にて溶解、撹拌した後、必要に応じてpHを調整し、さらに精製水を加えて容量調整し、必要に応じてろ過処理や殺菌処理をし、容器に充填して、加熱殺菌をし、必要に応じて冷却する工程により製造することができる。好ましくは、原料の全部又は一部を90~130℃で1秒~5分間殺菌し、さらに10~40℃程度に冷却して製造するのがよい。殺菌には通常の殺菌機を用いればよく、例えば、プレート式殺菌機、チューブラー式殺菌機、ジャケット付きタンク等を使用することができる。また、冷却には通常の冷却機を用いればよく、例えば、熱交換プレート、チューブラー式冷却機、ジャケット付きタンク等を使用することができる。 The beverage of the present invention can be produced by a conventional method, and the method is not particularly limited. When the beverage of the present invention is made into a liquid beverage, for example, each component is weighed, dissolved in an appropriate amount of purified water, stirred, and then the pH is adjusted as necessary, and purified water is added to adjust the volume. It can be manufactured by performing filtration treatment or sterilization treatment as necessary, filling a container, heat sterilization, and cooling as necessary. Preferably, all or part of the raw materials are sterilized at 90 to 130°C for 1 second to 5 minutes, and then further cooled to about 10 to 40°C. For sterilization, a normal sterilizer may be used, such as a plate type sterilizer, a tubular type sterilizer, a jacketed tank, etc. Further, a normal cooler may be used for cooling, and for example, a heat exchange plate, a tubular type cooler, a jacketed tank, etc. can be used.
また、本発明の飲料をゼリー飲料とする場合、例えば、各成分をはかりとり、適量の精製水に分散及び/又は溶解させた後、必要に応じて加熱、pHを調整し、残りの精製水を加えて容量調製し、必要に応じてろ過処理や加熱殺菌をし、容器に充填して、加熱殺菌をし、必要に応じて冷却する工程により製造することができる。 In addition, when the beverage of the present invention is made into a jelly beverage, for example, each component is weighed, dispersed and/or dissolved in an appropriate amount of purified water, heated as necessary, the pH is adjusted, and the remaining purified water is It can be manufactured by adding the following steps to adjust the volume, subjecting it to filtration treatment or heat sterilization as necessary, filling it into a container, heat sterilization, and cooling as necessary.
以下に、実施例等を挙げ、本発明を更に詳細に説明するが、本発明はこれらの実施例等に何ら限定されるものではない。なお、以下の実施例、比較例では、マルトデキストリンは松谷化学工業(株)製のTK-16(DE18)、ビタミンB2類はDSM(株)製のリボフラビン、イソマルツロースは三井製糖(株)製の結晶パラチノースPST-N、ジェランガムはネイティブ型ジェランガムを用い、クエン酸一水和物、クエン酸三ナトリウム二水和物は食品添加物のものを用いた。 The present invention will be described in more detail below with reference to Examples, but the present invention is not limited to these Examples. In the following examples and comparative examples, maltodextrin is TK-16 (DE18) manufactured by Matsutani Chemical Co., Ltd., vitamin B2 is riboflavin manufactured by DSM Co., Ltd., and isomaltulose is manufactured by Mitsui Sugar Co., Ltd. Crystalline Palatinose PST-N manufactured by Manufacturer Co., Ltd., native type gellan gum was used, and citric acid monohydrate and trisodium citrate dihydrate were food additives.
<飲料の調製>
(比較例1)
まず、10mg/100gとなるようにリボフラビンを精製水(温水)に溶解させたリボフラビン溶液と、精製水にクエン酸一水和物、クエン酸三ナトリウム二水和物およびイソマルツロースを添加し、溶解させ、それぞれの濃度が1.0g/27g、0.5g/27g、5.0g/27gとなるようなクエン酸・イソマルツロース溶液を調製した。
次に、最終的な処方量になるようにリボフラビン溶液およびクエン酸・イソマルツロース溶液をはかりとり、マルトデキストリンを添加し、よく撹拌したのちに全量調整し、サンプル溶液を調製した。調製したサンプル溶液はスクリュー管(マルエム社製、No.6)に30mLずつ充填し、85℃で20分間の殺菌を行い、飲料(液体飲料)を調製した。
<Beverage preparation>
(Comparative example 1)
First, a riboflavin solution in which riboflavin was dissolved in purified water (warm water) at a concentration of 10 mg/100 g, and citric acid monohydrate, trisodium citrate dihydrate, and isomaltulose were added to the purified water. Citric acid/isomaltulose solutions were prepared so that the respective concentrations were 1.0 g/27 g, 0.5 g/27 g, and 5.0 g/27 g.
Next, the riboflavin solution and the citric acid/isomaltulose solution were weighed out to the final prescribed amount, maltodextrin was added, and after thorough stirring, the total amount was adjusted to prepare a sample solution. The prepared sample solution was filled in screw tubes (manufactured by Maruem Co., Ltd., No. 6) in an amount of 30 mL each, and sterilized at 85° C. for 20 minutes to prepare a drink (liquid drink).
(実施例1~3、比較例2、4、5)
まず、10mg/100gとなるようにリボフラビンを精製水(温水)に溶解させたリボフラビン溶液と、精製水にクエン酸一水和物およびクエン酸三ナトリウム二水和物、イソマルツロースを添加し、それぞれの濃度が1.0g/54g、0.5g/54g、5g/54gとなるようなクエン酸・イソマルツロース溶液を調製した。
次に、最終的な処方量になるようにリボフラビン溶液およびクエン酸・イソマルツロース溶液をはかりとり、必要に応じてマルトデキストリンを添加し、よく撹拌し、溶解させたのちに全量調整し、サンプル溶液を調製した。調製したサンプル溶液はスクリュー管(マルエム社製、No.6)に30mLずつ充填し、85℃で20分間の殺菌を行い、飲料(液体飲料)を調製した。
(Examples 1 to 3, Comparative Examples 2, 4, 5)
First, a riboflavin solution prepared by dissolving riboflavin in purified water (warm water) at a concentration of 10 mg/100 g, citric acid monohydrate, trisodium citrate dihydrate, and isomaltulose are added to the purified water. Citric acid/isomaltulose solutions were prepared with respective concentrations of 1.0 g/54 g, 0.5 g/54 g, and 5 g/54 g.
Next, measure the riboflavin solution and citric acid/isomaltulose solution to the final prescribed amount, add maltodextrin as necessary, stir well, dissolve, adjust the total volume, and sample. A solution was prepared. The prepared sample solution was filled in screw tubes (manufactured by Maruem Co., Ltd., No. 6) in an amount of 30 mL each, and sterilized at 85° C. for 20 minutes to prepare a drink (liquid drink).
(実施例4、5、比較例3)
まず、10mg/100gとなるようにリボフラビンを精製水(温水)に溶解させたリボフラビン溶液と、精製水にクエン酸一水和物およびクエン酸三ナトリウム二水和物を添加し、それぞれの濃度が1.0g/54g、0.5g/54gとなるようなクエン酸溶液を調製した。
次に、最終的な処方量になるようにリボフラビン溶液およびクエン酸溶液をはかりとり、マルトデキストリンを添加し、必要に応じてイソマルツロースを添加し、よく撹拌し、溶解させたのちに全量調整し、サンプル溶液を調製した。調製したサンプル溶液はスクリュー管(マルエム社製、No.6)に30mLずつ充填し、85℃で20分間の殺菌を行い、飲料(液体飲料)を調製した。
(Examples 4 and 5, Comparative Example 3)
First, a riboflavin solution prepared by dissolving riboflavin in purified water (warm water) at a concentration of 10 mg/100 g, and citric acid monohydrate and trisodium citrate dihydrate were added to the purified water, and the respective concentrations were adjusted. Citric acid solutions of 1.0g/54g and 0.5g/54g were prepared.
Next, measure the riboflavin solution and citric acid solution to the final prescribed amount, add maltodextrin, add isomaltulose if necessary, stir well, dissolve, and adjust the total amount. and prepared a sample solution. The prepared sample solution was filled in screw tubes (manufactured by Maruem Co., Ltd., No. 6) in an amount of 30 mL each, and sterilized at 85° C. for 20 minutes to prepare a drink (liquid drink).
(比較例4、5)
まず、10mg/100gとなるようにリボフラビンを精製水(温水)に溶解させたリボフラビン溶液と、精製水にクエン酸一水和物およびクエン酸三ナトリウム二水和物、イソマルツロースを添加し、溶解させ、それぞれの濃度が1.0g/27g、0.5g/27g、5.0g/27gとなるようなクエン酸・イソマルツロース溶液を調製した。
次に、最終的な処方量になるようにリボフラビン溶液およびクエン酸・パラチノース溶液をはかりとり、必要に応じてマルトデキストリンを添加し、よく撹拌し、溶解させたのちに全量調整し、サンプル溶液を調製した。調製したサンプル溶液はスクリュー管(マルエム社製、No.6)に30mLずつ充填し、85℃で20分間の殺菌を行い、飲料(液体飲料)を調製した。
(Comparative Examples 4 and 5)
First, a riboflavin solution prepared by dissolving riboflavin in purified water (warm water) at a concentration of 10 mg/100 g, citric acid monohydrate, trisodium citrate dihydrate, and isomaltulose are added to the purified water. Citric acid/isomaltulose solutions were prepared so that the respective concentrations were 1.0 g/27 g, 0.5 g/27 g, and 5.0 g/27 g.
Next, measure the riboflavin solution and citric acid/palatinose solution to the final prescribed amount, add maltodextrin as necessary, stir well, dissolve, adjust the total volume, and add the sample solution. Prepared. The prepared sample solution was filled in screw tubes (manufactured by Maruem Co., Ltd., No. 6) in an amount of 30 mL each, and sterilized at 85° C. for 20 minutes to prepare a drink (liquid drink).
(実施例6、比較例6)
まず、10mg/100gとなるようにリボフラビンを精製水(温水)に溶解させたリボフラビン溶液と、精製水にクエン酸一水和物、クエン酸三ナトリウム二水和物およびイソマルツロースを添加し、溶解させ、それぞれの濃度が1.0g/27g、0.5g/27g、5.0g/27gとなるようなクエン酸・イソマルツロース溶液を調製した。
次に、0.36g/90gとなるように精製水にネイティブ型ジェランガムを添加し、分散させ、攪拌させながら100℃まで加熱をし、100℃で3分間、温度を維持し、ジェランガム溶液を調製した。調製したジェランガム溶液は、温度を70℃以上で維持したまま攪拌をさせておいた。
その後、最終的な処方量になるようにジェランガム溶液、リボフラビン溶液およびクエン酸・イソマルツロース溶液をはかりとり、必要に応じてマルトデキストリンを添加し、よく撹拌し、溶解させたのちに全量調整し、サンプル溶液を調製した。調製したサンプル溶液は透明なスタンディングパウチ(ヤマトマテリアル社製、Ibis 100-SP)に100gずつ充填し、85℃で20分間の殺菌を行い、その後水冷し、飲料(ゼリー飲料)を調製した。
(Example 6, Comparative Example 6)
First, a riboflavin solution in which riboflavin was dissolved in purified water (warm water) at a concentration of 10 mg/100 g, and citric acid monohydrate, trisodium citrate dihydrate, and isomaltulose were added to the purified water. Citric acid/isomaltulose solutions were prepared so that the respective concentrations were 1.0 g/27 g, 0.5 g/27 g, and 5.0 g/27 g.
Next, native gellan gum was added to purified water at a ratio of 0.36g/90g, dispersed, heated to 100°C while stirring, and maintained at 100°C for 3 minutes to prepare a gellan gum solution. did. The prepared gellan gum solution was stirred while maintaining the temperature at 70° C. or higher.
Then, weigh out the gellan gum solution, riboflavin solution, and citric acid/isomaltulose solution to the final prescribed amount, add maltodextrin as necessary, stir well, dissolve, and adjust the total amount. , a sample solution was prepared. The prepared sample solution was filled in transparent standing pouches (Ibis 100-SP, manufactured by Yamato Materials Co., Ltd.) in an amount of 100 g each, sterilized at 85° C. for 20 minutes, and then cooled with water to prepare a drink (jelly drink).
(実施例7~10、比較例7)
まず、10mg/100gとなるようにリボフラビンを精製水(温水)に溶解させたリボフラビン溶液と、精製水に100mg/100gとなるようにチアミン硝酸塩を溶解させたチアミン溶液と、精製水にクエン酸一水和物、クエン酸三ナトリウム二水和物、イソマルツロースおよびマルトデキストリンを添加し、溶解させ、それぞれの濃度が1.0g/108g、0.5g/108g、5.0g/108g、28.0g/108gとなるようなクエン酸・イソマルツロース・マルトデキストリン溶液を調製した。
次に、最終的な処方量になるようにリボフラビン溶液、チアミン溶液、クエン酸・イソマルツロース・マルトデキストリン溶液をはかりとり、よく撹拌させたのちに全量調整し、サンプル溶液を調製した。調製したサンプル溶液はスクリュー管(マルエム社製、No.6)に30mLずつ充填し、85℃で20分間の殺菌を行い、飲料(液体飲料)を調製した。
(Examples 7 to 10, Comparative Example 7)
First, a riboflavin solution in which riboflavin was dissolved in purified water (warm water) to give a concentration of 10 mg/100 g, a thiamine solution in which thiamine nitrate was dissolved in purified water to a concentration of 100 mg/100 g, and a thiamine solution in which thiamine nitrate was dissolved in purified water to a concentration of 100 mg/100 g. hydrate, trisodium citrate dihydrate, isomaltulose and maltodextrin are added and dissolved to give respective concentrations of 1.0g/108g, 0.5g/108g, 5.0g/108g, 28. A citric acid/isomaltulose/maltodextrin solution with a ratio of 0g/108g was prepared.
Next, the riboflavin solution, thiamin solution, and citric acid/isomaltulose/maltodextrin solution were weighed out to the final prescribed amounts, stirred thoroughly, and the total amount was adjusted to prepare a sample solution. The prepared sample solution was filled in screw tubes (manufactured by Maruem Co., Ltd., No. 6) in an amount of 30 mL each, and sterilized at 85° C. for 20 minutes to prepare a drink (liquid drink).
(実施例11、12)
まず、10mg/100gとなるようにリボフラビンを精製水(温水)に溶解させたリボフラビン溶液を調製した。
次に、ネイティブ型ジェランガムとイソマルツロースを粉体混合し、それぞれの濃度が約0.36g/90gおよび約5.0g/90gとなるように精製水に添加し、分散させ、攪拌させながら100℃まで加熱をし、100℃で3分間、温度を維持した。その後、温度を70℃以上で維持したまま、マルトデキストリン、クエン酸一水和物、クエン酸三ナトリウム二水和物、リボフラビン溶液を添加し、それぞれの濃度が28.0g/162g、1.0g/162g、0.5g/162g、2.0mg/162gとなるような共通溶液を調製した。なお、調製した共通溶液は、温度を70℃以上で維持したまま攪拌をさせておいた。
その後、最終的な処方量になるように共通溶液をはかりとり、必要に応じてチアミン硝酸塩を添加し、よく撹拌し、溶解させたのちに全量調整し、サンプル溶液を調製した。調製したサンプル溶液は透明なスタンディングパウチ(ヤマトマテリアル社製、Ibis 100-SP)に100gずつ充填し、85℃で20分間の殺菌を行い、その後水冷し、飲料(ゼリー飲料)を調製した。
(Example 11, 12)
First, a riboflavin solution was prepared by dissolving riboflavin in purified water (warm water) to a concentration of 10 mg/100 g.
Next, native gellan gum and isomaltulose were mixed in powder form, added to purified water so that the respective concentrations were approximately 0.36 g/90 g and approximately 5.0 g/90 g, dispersed, and heated to 100 g while stirring. The mixture was heated to 100°C and maintained at 100°C for 3 minutes. Then, while maintaining the temperature at 70°C or above, maltodextrin, citric acid monohydrate, trisodium citrate dihydrate, and riboflavin solution were added, and the respective concentrations were 28.0g/162g and 1.0g. /162g, 0.5g/162g, and 2.0mg/162g common solutions were prepared. Note that the prepared common solution was stirred while maintaining the temperature at 70° C. or higher.
Thereafter, the common solution was weighed out to the final prescribed amount, thiamine nitrate was added as needed, stirred well to dissolve, and the total amount was adjusted to prepare a sample solution. The prepared sample solution was filled in transparent standing pouches (Ibis 100-SP, manufactured by Yamato Materials Co., Ltd.) in an amount of 100 g each, sterilized at 85° C. for 20 minutes, and then cooled with water to prepare a drink (jelly drink).
<試験例1:リボフラビンの残存率の算出>
表1~4に示す実施例1~6及び比較例1~6の飲料に関して、5℃暗所保管した飲料中のリボフラビン量と、遮光した状態で、65℃の恒温槽にて5日間保管したのち室温に戻し、遮光を外して、光試験機にてCIE標準光源D65で3000Luxにて15分間の光照射を行った飲料中のリボフラビン量を、それぞれHPLC(液体クロマトグラフィー)法を用いてn=3で測定した。5℃暗所保管した飲料中のリボフラビン量の平均値に対し、遮光した状態で、65℃の恒温槽にて5日間保管したのち室温に戻し、遮光を外して、光試験機にてCIE標準光源D65で3000Luxにて15分間の光照射を行った飲料中のリボフラビン量の平均値を、リボフラビンの残存率(%)として算出した。実施例1~6及び比較例1~6の算出結果を表1~4に示す。
<Test Example 1: Calculation of residual rate of riboflavin>
Regarding the drinks of Examples 1 to 6 and Comparative Examples 1 to 6 shown in Tables 1 to 4, the amount of riboflavin in the drinks stored in the dark at 5°C and the amount of riboflavin in the drinks stored in a constant temperature bath at 65°C in the dark for 5 days. After that, the temperature was returned to room temperature, the light shielding was removed, and the amount of riboflavin in the drink was irradiated with light for 15 minutes at 3000 Lux using a CIE standard light source D65 using an optical tester, using the HPLC (liquid chromatography) method. =3. The average amount of riboflavin in beverages stored in the dark at 5°C was stored in a constant temperature bath at 65°C with protection from light for 5 days, then returned to room temperature, removed from light, and tested with a light tester to meet the CIE standard. The average value of the amount of riboflavin in the beverage that was irradiated with light at 3000 Lux for 15 minutes using light source D65 was calculated as the residual rate (%) of riboflavin. The calculation results for Examples 1 to 6 and Comparative Examples 1 to 6 are shown in Tables 1 to 4.
表1で示すように、実施例1と比較例1とはリボフラビンの濃度が異なるだけであるが、実施例1は比較例1と比較してリボフラビンの残存率は顕著に高かった。また、比較例2、3と実施例1から、マルトデキストリンとイソマルツロースの両方を配合した実施例1の方がリボフラビンの残存率は顕著に高かった。 As shown in Table 1, although Example 1 and Comparative Example 1 differed only in the concentration of riboflavin, the residual rate of riboflavin in Example 1 was significantly higher than in Comparative Example 1. Further, from Comparative Examples 2 and 3 and Example 1, the residual rate of riboflavin was significantly higher in Example 1 in which both maltodextrin and isomaltulose were blended.
表2で示すように、リボフラビンの残存率はマルトデキストリンの量に依存して高まることが分かった。比較例4から、マルトデキストリンが低濃度だとかえってリボフラビンの残存率は低くなることが分かった。実施例1~3に示すように、マルトデキストリンの濃度が15w/w%以上の場合、リボフラビンの残存率は高かった。 As shown in Table 2, the residual rate of riboflavin was found to increase depending on the amount of maltodextrin. From Comparative Example 4, it was found that when the concentration of maltodextrin was low, the residual rate of riboflavin was rather low. As shown in Examples 1 to 3, when the concentration of maltodextrin was 15 w/w% or more, the residual rate of riboflavin was high.
表3で示す通り、イソマルツロースの濃度に依存して、リボフラビンの残存率が高くなることが分かった。 As shown in Table 3, it was found that the residual rate of riboflavin increased depending on the concentration of isomaltulose.
表4で示す通り、剤形がゼリーにおいても、マルトデキストリンを配合しない比較例6と比べて、マルトデキストリンを配合した実施例6のほうが、リボフラビンの残存率は顕著に高かった。また、剤形は液体よりもゼリーのほうが、リボフラビンの残存率の低下は顕著に抑制できた。したがって、剤形によらず、リボフラビンの残存率の低下が抑制できると考えられた。 As shown in Table 4, even in the jelly dosage form, the residual rate of riboflavin was significantly higher in Example 6, which contained maltodextrin, than in Comparative Example 6, which did not contain maltodextrin. In addition, the decrease in the residual rate of riboflavin was more significantly suppressed when the dosage form was a jelly rather than a liquid. Therefore, it was considered that the decrease in the residual rate of riboflavin could be suppressed regardless of the dosage form.
<試験例2:不快臭の評価>
表5、6の実施例7~12、及び比較例7の飲料の、室温での不快臭を評価した。
遮光した状態で、40℃75%RHの恒湿恒温槽にて5日間保管したのち室温に戻し、遮光を外して、光試験機にてCIE標準光源D65で3000Luxにて24時間の光照射を行った飲料を、表7に示す評価基準で、試験者3名で絶対評価した。
なお、飲料はそれぞれの試験者ごとに別のものを使用し、飲料(液体飲料)に関しては、スクリュー管から直接においをかいで評価し、飲料(ゼリー飲料)に関しては、プロマックスカップ(旭化成パックス製、EI―90D)に約25g注いだ状態でにおいをかいで評価し、各試験者の評価点の平均値を算出した。評価結果を表5、6に示す。
<Test Example 2: Evaluation of unpleasant odor>
The unpleasant odor of the drinks of Examples 7 to 12 and Comparative Example 7 in Tables 5 and 6 at room temperature was evaluated.
After storing it in a constant humidity and temperature chamber at 40°C and 75% RH for 5 days with light shielding, it was returned to room temperature, the light shield was removed, and light was irradiated for 24 hours at 3000 Lux with CIE standard light source D65 using a light tester. The drinks were absolutely evaluated by three testers using the evaluation criteria shown in Table 7.
In addition, each tester used a different beverage, and the beverage (liquid beverage) was evaluated by smelling it directly from the screw tube, and the beverage (jelly beverage) was evaluated using a Promax Cup (Asahi Kasei Pax). Approximately 25g of the sample was poured into a container (EI-90D, manufactured by EI-90D) and evaluated by smelling it, and the average value of each tester's evaluation score was calculated. The evaluation results are shown in Tables 5 and 6.
表5の実施例7と実施例8~10で示す通り、チアミン硝酸塩を配合しない実施例7よりも、チアミン硝酸塩を配合した実施例8~10のほうが、評価点が低くなり、不快臭を顕著に緩和していた。しかしながら、実施例7と比較例7に示す通り、チアミン硝酸塩の配合量が多すぎると、チアミン硝酸塩配合していないときの評価点と変わらなかった。したがって、特定の濃度以下のチアミン硝酸塩を配合することで、不快臭を顕著に緩和できると考えられた。 As shown in Example 7 and Examples 8 to 10 in Table 5, Examples 8 to 10 in which thiamine nitrate was blended had lower evaluation scores than Example 7 in which thiamine nitrate was not blended, and the unpleasant odor was noticeably lower. It was relaxing. However, as shown in Example 7 and Comparative Example 7, when the amount of thiamine nitrate blended was too large, the evaluation score was the same as when thiamine nitrate was not blended. Therefore, it was considered that unpleasant odors could be significantly alleviated by incorporating thiamine nitrate at a specific concentration or less.
表6で示す通り、剤形がゼリーにおいても、チアミン硝酸塩を配合しない実施例11よりも、チアミン硝酸塩を配合する実施例12のほうが、評価点が低く、不快臭を顕著に緩和していた。また、剤形は液体よりもゼリーのほうが、不快臭を緩和できた。 したがって、剤形によらず、特定の濃度以下のチアミン硝酸塩を配合することで、不快臭を緩和できると考えられた。 As shown in Table 6, even in the jelly dosage form, Example 12, which contains thiamine nitrate, had a lower evaluation score than Example 11, which did not contain thiamine nitrate, and the unpleasant odor was significantly alleviated. In addition, the jelly dosage form was more effective at alleviating unpleasant odors than the liquid dosage form. Therefore, it was considered that unpleasant odors could be alleviated by incorporating thiamine nitrate at a specific concentration or less, regardless of the dosage form.
本発明により、ビタミンB2類、マルトデキストリン、及びイソマルツロースを含有し、ビタミンB2類の含量低下を抑制した飲料を提供することが可能となった。
また、ビタミンB2類、マルトデキストリン、イソマルツロースを含有し、ビタミンB2類由来の不快臭を緩和した飲料を提供することが可能となった。
According to the present invention, it has become possible to provide a beverage containing vitamin B2, maltodextrin, and isomaltulose, and suppressing a decrease in the content of vitamin B2.
Furthermore, it has become possible to provide a beverage that contains vitamin B2, maltodextrin, and isomaltulose and has alleviated the unpleasant odor derived from vitamin B2.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022068610A JP7099652B1 (en) | 2022-04-19 | 2022-04-19 | Beverages containing vitamin B2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022068610A JP7099652B1 (en) | 2022-04-19 | 2022-04-19 | Beverages containing vitamin B2 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP7099652B1 JP7099652B1 (en) | 2022-07-12 |
JP2023158690A true JP2023158690A (en) | 2023-10-31 |
Family
ID=82384786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022068610A Active JP7099652B1 (en) | 2022-04-19 | 2022-04-19 | Beverages containing vitamin B2 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7099652B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6460360A (en) * | 1987-08-31 | 1989-03-07 | Mitsui Sugar Co | Sport drink for supplying energy |
JP2003034643A (en) * | 2001-05-14 | 2003-02-07 | Shin Mitsui Sugar Co Ltd | Composition for sustaining power of concentration and power of attention and food-and-drink containing the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101943489B1 (en) | 2015-04-30 | 2019-01-29 | 주식회사 엘지화학 | Battery pack and method for manufacturing the same |
-
2022
- 2022-04-19 JP JP2022068610A patent/JP7099652B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6460360A (en) * | 1987-08-31 | 1989-03-07 | Mitsui Sugar Co | Sport drink for supplying energy |
JP2003034643A (en) * | 2001-05-14 | 2003-02-07 | Shin Mitsui Sugar Co Ltd | Composition for sustaining power of concentration and power of attention and food-and-drink containing the same |
Non-Patent Citations (2)
Title |
---|
ドリンクレビュー専門の総合サイト"ソフトドリンクの鉄人"に掲載された2022年 1月22日付け記事", JPN6022020754, ISSN: 0004787928 * |
大正製薬株式会社ウェブサイトに掲載された2021年 2月25日付けニュースリリース"全てのアスリート, JPN6022020755, ISSN: 0004787929 * |
Also Published As
Publication number | Publication date |
---|---|
JP7099652B1 (en) | 2022-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI526161B (en) | Substantially clear nutritional liquids comprising calcium hmb and soluble protein | |
RU2512330C2 (en) | Gel-based composition and its production methods | |
CA2330061C (en) | Nutritionally complete low ph enteral formula | |
EA003376B1 (en) | Compositions containing creatine suspension | |
JP2000511054A (en) | Improvements or related improvements in compositions containing creatine | |
KR101367741B1 (en) | Compositions comprising garcinia cambogia extract and methods for preparing the same | |
BRPI0014287B1 (en) | composition comprising water, juices, beverages or other reinforced liquid food products, as well as their preparation processes | |
CN103037715A (en) | Nutritional compositions | |
JP2006315985A (en) | Method for suppressing deterioration of vitamin | |
CZ290798B6 (en) | Process for preparing creatine beverage | |
US5178896A (en) | Fiber beverage and method of manufacture | |
TW201138859A (en) | Oral rehydration solutions comprising dextrose | |
JPH04501511A (en) | Liquid beverages and tube feedings containing stable guar flour | |
JP2004504824A (en) | Fiber formula | |
CN103859039A (en) | Liquid milk composition beneficial for improving children immunity | |
JP7099652B1 (en) | Beverages containing vitamin B2 | |
KR101444875B1 (en) | Beverage composition comprising hibiscus extract and l-carnitine with improved sensory property and stability | |
JP3507722B2 (en) | Method for producing calcium-containing transparent soft drink | |
JP2007185187A (en) | Method for preparing low calorie jelly | |
JPH0698729A (en) | Ginseng extract-containing beverage and its production | |
KR20000065465A (en) | Nutritional Drink of Containing Extracts of Oyster Shell and Method of Manufacturing Thereof | |
JP4431316B2 (en) | Anti-constipation composition | |
JP2022176140A (en) | Composition for frozen beverage | |
JP2024050456A (en) | Vitamin B1-containing oral composition | |
JP2022162982A (en) | Vitamin b2-containing oral liquid composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220422 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220422 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220531 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220613 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7099652 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |